FDA says India plant falsified generic drug data
The Food and Drug Administration said Wednesday that it has stopped reviewing drug applications from an India-based pharmaceutical plant, alleging that officials there falsified data and test results in applications, some of which the agency has already approved.div class=”feedflare”
a href=”http://rss.cnn.com/~ff/rss/cnn_world?a=edwaJYKS6bc:b6C24qvwpzA:yIl2AUoC8zA”img src=”http://feeds2.feedburner.com/~ff/rss/cnn_world?d=yIl2AUoC8zA” border=”0″/img/a a href=”http://rss.cnn.com/~ff/rss/cnn_world?a=edwaJYKS6bc:b6C24qvwpzA:7Q72WNTAKBA”img src=”http://feeds2.feedburner.com/~ff/rss/cnn_world?d=7Q72WNTAKBA” border=”0″/img/a a href=”http://rss.cnn.com/~ff/rss/cnn_world?a=edwaJYKS6bc:b6C24qvwpzA:V_sGLiPBpWU”img src=”http://feeds2.feedburner.com/~ff/rss/cnn_world?i=edwaJYKS6bc:b6C24qvwpzA:V_sGLiPBpWU” border=”0″/img/a a href=”http://rss.cnn.com/~ff/rss/cnn_world?a=edwaJYKS6bc:b6C24qvwpzA:qj6IDK7rITs”img src=”http://feeds2.feedburner.com/~ff/rss/cnn_world?d=qj6IDK7rITs” border=”0″/img/a a href=”http://rss.cnn.com/~ff/rss/cnn_world?a=edwaJYKS6bc:b6C24qvwpzA:gIN9vFwOqvQ”img src=”http://feeds2.feedburner.com/~ff/rss/cnn_world?i=edwaJYKS6bc:b6C24qvwpzA:gIN9vFwOqvQ” border=”0″/img/a
/divimg src=”http://feeds2.feedburner.com/~r/rss/cnn_world/~4/edwaJYKS6bc” height=”1″ width=”1″/
Original post by WP-AutoBlog Import